DrugsControl Media Services
DrugsControl.org

News Detail

Aurobindo arm’s facility in Rajasthan gets 7 US FDA observations (04-05-2024)

Hyderabad, 4 May 2024: Aurobindo Pharma, on Friday, May 3, said it has received seven observations from the United States Food and Drug Administration ( US FDA) for its unit-II formulation manufacturing facility located in Bhiwadi, Rajasthan.

 

The FDA conduc......
View Details

Source : CNBC-TV18
usfda usfda aurobindo pharma aurobindo pharma aurobindo pharma bhiwadi facility aurobindo pharma bhiwadi manufacturing facility

Related News